Integra Lifesciences Holdings Corp (IART), NuVasive, Inc. (NUVA), CareFusion Corporation (CFN): A Solid Orthopedic Implants Manufacturer

Page 1 of 2

The orthopedic implants market is a growing segment with increasing demand for extremities, spine, and orthobiologics. Large companies like Depuy/Synthes from Johnson & Johnson, Medtronic, Zimmer, and Stryker are majority players in the market. However, the sector offers opportunities for small and mid-sized players with cost-efficient operations and competitive pricing. New Jersey-based Integra Lifesciences Holdings Corp (NASDAQ:IART) is a mid-sized company that offers a wide range of products, devices, and instruments for orthopedic and neurosurgery.

Integra Lifesciences Holdings Corp

Background

Integra Lifesciences Holdings Corp (NASDAQ:IART), a $1.07 billion medical technology company, is a leading provider of surgical instruments to hospitals, surgery centers, and clinics in the U.S. The company primarily develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, orthopedic extremity, spine, and reconstructive surgery. The company has a patented technology to develop soft tissue products.

Integra Lifesciences Holdings Corp (NASDAQ:IART) offers products in three core businesses including regenerative products (soft tissue products), medical devices, and instruments that can be used in neurosurgery, orthopedic, and general surgery. It develops soft tissue products based on its proprietary collagen matrix and de-mineralized bone matrix technologies. The tissue-engineered products are approved by the FDA to use in neurosurgery, orthopedic, and general surgery.

Key target market

Around 100 million people in the U.S. and nearly 2 billion worldwide suffer from brain or nervous system disorders. These include depression, anxiety, epilepsy, Alzheimer’s, Parkinson’s, and other related disorders. The market growth is driven by increasing neurological disorders and technological advancement. The market is largely captured by J&J, Medtronic, and Stryker. Integra Lifesciences Holdings Corp (NASDAQ:IART) offers a variety of products used in neurosurgery. Of these, systems are used to measure various brain parameters, devices to access brain and clean excess liquid from the brain; tissue repair through ultrasonic surgery systems, and dural grafts to repair the brain’s internal structure.

Orthobiologics is a growing segment within the orthopedic market. The U.S. orthobiologics market is expected to grow at a compounded annual growth rate of 15% to reach $6 billion in 2016. The growth is primarily driven by increasing elderly population, higher obesity, rising sports injuries and road accidents, and increasing patients’ awareness toward novel products. Technological advances such as nanotechnology will support growth in the industry. Besides large players, medium-sized companies like Wright Medical, NuVasive, Inc. (NASDAQ:NUVA), and Integra Lifesciences Holdings Corp (NASDAQ:IART) have some presence due to their innovative products and technologies. Integra develops products for bone repair made from its owned de-mineralized bone matrix technology.

Around 10 million adults in the U.S. suffer from chronic back pain each year. The majority have pain due to compression of nerves either in the spine or legs. In most cases, patients are treated with painkillers, physical therapy, steroid injections, or are suggested to change their lifestyle. However, lately the spine market isn’t doing all that well in the U.S.

Integra’s competitive landscape

In spine surgery, Integra competes with NuVasive, Inc. (NASDAQ:NUVA), the fourth-largest player in spine segment globally. The company offers a comprehensive range of spine products (more than 80 unique products) used for spine surgery. Its Maximum Access Surgery, or MAS, platform is used for lateral spine fusion. The company has a strong cash balance of $272.7 million, which will comfortably see it through growth and R&D in the near future. However, the company is facing multiple Medicare-related lawsuits, and analysts are not sure how it can hit a 20% growth in operating margins as predicted by management.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!